Palisade Bio Stock Three Year Return
| PALI Stock | USD 1.77 0.06 3.51% |
Palisade Bio fundamentals help investors to digest information that contributes to Palisade Bio's financial success or failures. It also enables traders to predict the movement of Palisade Stock. The fundamental analysis module provides a way to measure Palisade Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Palisade Bio stock.
Palisade | Three Year Return |
Palisade Bio Company Three Year Return Analysis
Palisade Bio's Tree Year Return shows the total annualized return generated from holding a fund or ETFs for the last three years. The return measure includes capital appreciation, losses, dividends paid, and all capital gains distributions. This return indicator is considered by many investors to be solid measures of fund mid-term performance.
More About Three Year Return | All Equity Analysis
Three Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Palisade Three Year Return Driver Correlations
Understanding the fundamental principles of building solid financial models for Palisade Bio is extremely important. It helps to project a fair market value of Palisade Stock properly, considering its historical fundamentals such as Three Year Return. Since Palisade Bio's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Palisade Bio's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Palisade Bio's interrelated accounts and indicators.
Click cells to compare fundamentals
Although Three Year Fund Return indicator can give a sense of overall fund mid-term potential, it is recommended to compare fund performances against other similar funds, ETFs, or market benchmarks for the same 3 year interval.
| Competition |
Palisade Return On Tangible Assets
Return On Tangible Assets |
|
Based on the latest financial disclosure, Palisade Bio has a Three Year Return of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Palisade Three Year Return Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Palisade Bio's direct or indirect competition against its Three Year Return to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Palisade Bio could also be used in its relative valuation, which is a method of valuing Palisade Bio by comparing valuation metrics of similar companies.Palisade Bio is currently under evaluation in three year return category among its peers.
Palisade Bio Current Valuation Drivers
We derive many important indicators used in calculating different scores of Palisade Bio from analyzing Palisade Bio's financial statements. These drivers represent accounts that assess Palisade Bio's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Palisade Bio's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 513.3M | 167.9M | 219.7M | 4.0M | 4.6M | 4.4M | |
| Enterprise Value | 512.5M | 162.9M | 220.4M | (8.0M) | (9.2M) | (8.8M) |
Palisade Fundamentals
| Return On Equity | -1.1 | ||||
| Return On Asset | -0.59 | ||||
| Current Valuation | (2.61 M) | ||||
| Shares Outstanding | 2.77 M | ||||
| Shares Owned By Insiders | 1.88 % | ||||
| Shares Owned By Institutions | 3.57 % | ||||
| Number Of Shares Shorted | 1.84 M | ||||
| Price To Earning | 0.16 X | ||||
| Price To Book | 0.77 X | ||||
| Price To Sales | 14.03 X | ||||
| Revenue | 250 K | ||||
| EBITDA | (12.28 M) | ||||
| Net Income | (12.3 M) | ||||
| Cash And Equivalents | 5 M | ||||
| Cash Per Share | 0.23 X | ||||
| Total Debt | 369 K | ||||
| Debt To Equity | 0.23 % | ||||
| Current Ratio | 2.59 X | ||||
| Book Value Per Share | 18.30 X | ||||
| Cash Flow From Operations | (11.13 M) | ||||
| Short Ratio | 0.29 X | ||||
| Earnings Per Share | (13.26) X | ||||
| Target Price | 30.33 | ||||
| Beta | 1.33 | ||||
| Market Capitalization | 5.07 M | ||||
| Total Asset | 14.05 M | ||||
| Retained Earnings | (121.51 M) | ||||
| Working Capital | 10.74 M | ||||
| Net Asset | 14.05 M |
About Palisade Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Palisade Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Palisade Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Palisade Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Palisade Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Palisade Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Palisade Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Palisade Bio Stock:Check out Palisade Bio Piotroski F Score and Palisade Bio Altman Z Score analysis. For more detail on how to invest in Palisade Stock please use our How to Invest in Palisade Bio guide.You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Palisade Bio. If investors know Palisade will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Palisade Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (13.26) | Return On Assets (0.59) | Return On Equity (1.10) |
The market value of Palisade Bio is measured differently than its book value, which is the value of Palisade that is recorded on the company's balance sheet. Investors also form their own opinion of Palisade Bio's value that differs from its market value or its book value, called intrinsic value, which is Palisade Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Palisade Bio's market value can be influenced by many factors that don't directly affect Palisade Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Palisade Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Palisade Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Palisade Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.